Clinical Trials Logo

Lung Disease, Interstitial clinical trials

View clinical trials related to Lung Disease, Interstitial.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02990286 Completed - Clinical trials for Lung Disease, Interstitial

Evaluation of Efficacy and Safety of Rituximab With Mycophenolate Mofetil in Patients With Interstitial Lung Diseases

EvER-ILD
Start date: January 20, 2017
Phase: Phase 3
Study type: Interventional

The purpose of the study is to evaluate the efficacy on lung function 6 months after one course of rituximab (2 infusions) and mycophénolate mofétil (MMF) treatment compared to one course of placebo and 6 months of MMF treatment in a broad range of patients with Interstitial Lung Diseases (ILD) non-responders to a first line immunosuppressive treatment.

NCT ID: NCT01361139 Completed - Asthma Clinical Trials

Diagnosis of Cardio-Pulmonary Pathology Using Transthoracic Parametric Doppler (TPD)

Start date: August 2011
Phase: N/A
Study type: Observational

This is a study that seeks to characterize data obtained from patients with a variety of lung diseases using ultrasound signals obtained from the lung tissue. A standard ultrasound instrument in the doppler mode (not the imaging mode used in examination of pregnant women for instance) is placed on the chest wall and the unique software the investigators have developed analyzes the signal reflected back from within the lung. On the basis of pilot studies performed previously the investigators expect to receive different signals from different diseases. The investigators seek to further characterize these signals to enable accurate diagnosis of different lung diseases using our technology.

NCT ID: NCT00815711 Completed - Clinical trials for Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis Registry for Future Studies

Start date: December 1, 2008
Phase:
Study type: Observational

To establish a registry of patients for future studies of Inflammation in Interstitial Lung Disease/Idiopathic Pulmonary Fibrosis.